United Kingdom· GB-APID-10096811000001103
Glucose 50% solution for infusion 50ml ampoules
A medicinal product containing glucose, registered in United Kingdom by A A H Pharmaceuticals Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Glucose
- Manufacturer
- A A H Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Glucose in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaARDEANUTRISOL G 10%ARDEAPHARMA, a.s., Ševětín
- BelgiumBalance 1,5% Glucose 1,25 mmol/l CalciumFresenius Medical Care Deutschland
- SwitzerlandGlucose 5 % B. Braun, InfusionslösungB. Braun Medical AG
- Japanブドウ糖ニプロ
- SpainAPIROSERUM GLUCOSADO ISOTONICO SOLUCION PARA PERFUSIONFresenius Kabi España, S.A.U.
- FranceGLUCOSE 10 % AGUETTANT, solution pour perfusionAGUETTANT
- ItalyGLUCOSIO B.BRAUNB.BRAUN MELSUNGEN AG
- United StatesBlood Collection SystemGVS TM INC
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Glucose B. Braun, Glucose Fresenius
- Belgium · Glucose Aguettant, Glucose B. Braun
- Bulgaria · Глюкоза Бакстер, Глюкоза Браун
- Cyprus · Dextrose /Demo 20%, Dextrose Demo
- Czechia · Ardeanutrisol G, Glucose Fresenius Kabi
- Germany · Glucose B. Braun, Glucose Laboratoire Aguettant
- Denmark · Glucos B. Braun, Glucos Fresenius Kabi
- Estonia · Glucose B. Braun, Glucose B.Braun
- Spain · Dextrosa Fresenius Kabi, Freeflex Glucosa
- Finland · Glucos B. Braun, Glucos Fresenius Kabi
- France · Glucose Aguettant, Glucose B. Braun
- Greece · Dextrose Cooper, Dextrose Fresenius
- Croatia · Glukoza B. Braun, Glukoza Fresenius Kabi
- Hungary · Glucose B. Braun, Glucosum Pannonpharma
- Ireland · Glucose, Glucose Baxter Holding
- Iceland · Glucos Fresenius Kabi, Glucos Viaflo Baxter
- Italy · Glucorange, Glucosio
- Lithuania · Glucose B. Braun, Glucose B.Braun
- Luxembourg · Glucose, Glucose B. Braun
- Latvia · Glucose B.Braun, Glucose Fresenius
- Malta · Dextrose Vioser, Glucose Baxter Holding
- Netherlands · Glucose, Glucose 5% G/V
- Norway · Glucos B. Braun, Glucos Fresenius Kabi
- Poland · Gluco Test, Glucosi Baxter
- Portugal · Glucosada, Glucosada Grifols
- Romania · Dextrose Vioser, Glucose B Braun
- Sweden · Glucos B. Braun, Glucos Fresenius Kabi
- Slovenia · Glukoza Baxter, Glukoza Braun
- Slovakia · Glucose Fresenius Kabi, Glucose Intravenous Infusion B.P. Bieffe
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aef7f495-836d-4d22-8410-077559189122 GET /v1/drugs/aef7f495-836d-4d22-8410-077559189122?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "10096811000001103",
"desc": "Glucose 50% solution for infusion 50ml ampoules (A A H Pharmaceuticals Ltd)",
"form": "Solution for infusion",
"vpid": "4957211000001104",
"source": "dmd",
"vtm_id": "776119003",
"strength": "500 mg",
"substance": "Glucose",
"ingredient": "Glucose anhydrous",
"supplier_code": "3144701000001104"
}See everything about glucose.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.